Journal article
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients
Abstract
BACKGROUND & AIMS: Radiofrequency ablation (RFA) is an effective treatment for single hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients will occur outside transplant criteria. We aimed to assess the incidence and risk factors for recurrence beyond Milan criteria in potentially transplantable patients treated with RFA as first-line therapy.
METHODS: We performed a retrospective cohort study of potentially …
Authors
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP
Journal
Journal of Hepatology, Vol. 70, No. 5, pp. 866–873
Publisher
Elsevier
Publication Date
5 2019
DOI
10.1016/j.jhep.2018.12.027
ISSN
0168-8278